🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Some professionals said the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive reviews and detailed guides for mixing or administering at home.

After minutes of joining one community, a vendor shared contact information, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Details and Costs

Within these communities, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Although the science behind this drug is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially serious health risks”.